logo

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐[...]
Prostate cancer in kidney transplant recipients – a nationwide register study Abstract Objective To investigate whether post‐transplantation immunosuppression negatively affects pr[...]
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review Abstract Objective To assess the effects of pharmacologica[...]
The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression Abstract Objective To examine the assoc[...]
Update on the guideline of guidelines: non‐muscle‐invasive bladder cancer Abstract Non‐muscle‐invasive bladder cancer (NMIBC) is the most common form of bladder cancer, with freque[...]
Likert vs PI‐RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer Abstract Objective To compare the clinical validity a[...]
Exercise‐induced attenuation of treatment side‐effects in patients with newly diagnosed prostate cancer beginning androgen‐deprivation therapy: a randomised controlled trial Abstra[...]
Health‐related quality of life among non‐muscle‐invasive bladder cancer survivors: a population‐based study Abstract Objective To examine the effect of non‐muscle‐invasive bladder [...]
The role of extended venous thromboembolism prophylaxis for major urological cancer operations Abstract Objectives Venous thromboembolism (VTE), consisting of both pulmonary emboli[...]